Literature DB >> 20057321

Thrombotic complications of tunneled central lines in children with malignancy.

Tomasz Ociepa1, Eliza Maloney, Tomasz Urasinski, Marcin Sawicki.   

Abstract

BACKGROUND: The total rate of thrombotic complications caused by tunneled central lines (TCL) is still not known, as are the long-term consequences. AIM OF THE STUDY: Estimation of a rate of thrombotic complications in children with TCL and malignancy and Doppler ultrasound assessment of blood flow after TCL removal.
MATERIALS AND METHODS: One hundred twenty-four children were enrolled for the study. Heparin lock was used as a prophylaxis for line occlusion. The rate and type of thrombotic events associated with TCL were analyzed in all patients. In children without an earlier history of thrombosis, a Doppler ultrasound examination was carried out after TCL removal.
RESULTS: In 45.2% of patients at least 1 thrombotic event occurred. These events were TCL lumen thrombosis (42.8% of patients) and subclavian vein thrombosis (2.4% of patients). In 37 patients Doppler ultrasound was carried out and revealed an abnormal blood flow in the vein that was examined in 59.5% of them.
CONCLUSIONS: The total rate of thrombotic complications in children with TCL and malignancy is high. A substantial proportion of thrombotic complications can be clinically silent. The use of a heparin lock once a week seems far from effective in preventing thrombotic events in patients with TCL. The TCL life span has no influence on the rate of thrombotic events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057321     DOI: 10.1097/MPH.0b013e3181c09b0c

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience.

Authors:  Verena Wiegering; Sophie Schmid; Oliver Andres; Clemens Wirth; Armin Wiegering; Thomas Meyer; Beate Winkler; Paul G Schlegel; Matthias Eyrich
Journal:  BMC Hematol       Date:  2014-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.